Search Results - Yearley, Jennifer

Refine Results
  1. 1
    Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high fat/high cholesterol diet

    Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high fat/high cholesterol diet by Yearley, Jennifer H., Xia, Dongling, Pearson, Christine, Carville, Angela, Shannon, Richard P., Mansfield, Keith G.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma

    Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma by Owen, Dwight, Chu, Benjamin, Lehman, Amy M., Annamalai, Lakshmanan, Yearley, Jennifer H., Shilo, Konstantin, Otterson, Gregory A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma

    Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma by Tarhini, Ahmad A., Zahoor, Haris, Yearley, Jennifer H., Gibson, Christopher, Rahman, Zahra, Dubner, Rachel, Rao, Uma N. M., Sander, Cindy, Kirkwood, John M.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease

    High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease by Nota, Sjoerd P. F. T., Al-Sukaini, Ahmad, Patel, Shalin S., Sabbatino, Francesco, Nielsen, G. Petur, Deshpande, Vikram, Yearley, Jennifer H., Ferrone, Soldano, Wang, Xinhui, Schwab, Joseph H.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study

    Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study by Shui, Irene M., Liu, Xiao Qiao, Zhao, Qing, Kim, Seung Tae, Sun, Yuan, Yearley, Jennifer H., Choudhury, Tasmiah, Webber, Andrea L., Krepler, Clemens, Cristescu, Razvan, Lee, Jeeyun

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Immune phenotype of patients with stage IV metastatic inflammatory breast cancer

    Immune phenotype of patients with stage IV metastatic inflammatory breast cancer by Fernandez, Sandra V., MacFarlane, Alexander W., Jillab, Mowafaq, Arisi, Maria F., Yearley, Jennifer, Annamalai, Lakshmanan, Gong, Yulan, Cai, Kathy Q., Alpaugh, R. Katherine, Cristofanilli, Massimo, Campbell, Kerry S.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions

    Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions by Bauché, David, Mauze, Smita, Kochel, Christina, Grein, Jeff, Sawant, Anandi, Zybina, Yulia, Blumenschein, Wendy, Yang, Peng, Annamalai, Lakshmanan, Yearley, Jennifer H, Punnonen, Juha, Bowman, Edward P, Chackerian, Alissa, Laface, Drake

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    IMMU-11. AN ANALYSIS OF IMMUNOPHENOTYPE, INCLUDING PD-L1 AND PD1 EXPRESSION, IN PEDIATRIC CNS MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY

    IMMU-11. AN ANALYSIS OF IMMUNOPHENOTYPE, INCLUDING PD-L1 AND PD1 EXPRESSION, IN PEDIATRIC CNS MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY by Hwang, Eugene, Yang, Changling, Onar-Thomas, Arzu, Fangusaro, Jason, Gururangan, Sridharan, Yearley, Jennifer, Blumenschein, Wendy, McClanahan, Terri, Annamalai, Lakshman, Kocak, Mehmet, Partap, Sonia, Hummel, Trent, Dunkel, Ira, Fouladi, Maryam, Mitchell, Duane

    Published 2017
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers

    The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers by Barrett, Michael T., Lenkiewicz, Elizabeth, Malasi, Smriti, Basu, Anamika, Yearley, Jennifer Holmes, Annamalai, Lakshmanan, McCullough, Ann E., Kosiorek, Heidi E., Narang, Pooja, Wilson Sayres, Melissa A., Chen, Meixuan, Anderson, Karen S., Pockaj, Barbara A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Differential immune microenvironments and response to immune checkpoint blockade amongst molecular subtypes of murine medulloblastoma

    Differential immune microenvironments and response to immune checkpoint blockade amongst molecular subtypes of murine medulloblastoma by Pham, Christina D., Flores, Catherine, Yang, Changlin, Pinheiro, Elaine M., Yearley, Jennifer H., Sayour, Elias J., Pei, Yanxin, Moore, Colin, McLendon, Roger E., Huang, Jianping, Sampson, John H., Wechsler-Reya, Robert, Mitchell, Duane A.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

    IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade by Ayers, Mark, Lunceford, Jared, Nebozhyn, Michael, Murphy, Erin, Loboda, Andrey, Kaufman, David R., Albright, Andrew, Cheng, Jonathan D., Kang, S. Peter, Shankaran, Veena, Piha-Paul, Sarina A., Yearley, Jennifer, Seiwert, Tanguy Y., Ribas, Antoni, McClanahan, Terrill K.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE)

    Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE) by Chandramouleeswaran, Prasanna M., Shen, Dawen, Lee, Anna J., Benitez, Alain, Dods, Kara, Gambanga, Fiona, Wilkins, Benjamin J., Merves, Jamie, Noah, Yuliana, Toltzis, Sarit, Yearley, Jennifer H., Spergel, Jonathan M., Nakagawa, Hiroshi, Malefyt, Rene deWaal, Muir, Amanda B., Wang, Mei-Lun

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS

    CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS by Reardon, David, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Nayak, Lakshmi

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

    NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA by Nayak, Lakshmi, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Reardon, David

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma

    PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma by Sabbatino, Francesco, Villani, Vincenzo, Yearley, Jennifer H., Deshpande, Vikram, Cai, Lei, Konstantinidis, Ioannis T., Moon, Christina, Nota, Sjoerd, Wang, Yangyang, Al-Sukaini, Ahmad, Zhu, Andrew X., Goyal, Lipika, Ting, David T., Bardeesy, Nabeel, Hong, Theodore S., Castillo, Carlos Fernandez-del, Tanabe, Kenneth K., Lillemoe, Keith D., Ferrone, Soldano, Ferrone, Cristina R.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    A PILOT AND FEASIBILITY CLINICAL TRIAL EVALUATING IMMUNO-GENE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA (Ad.hIFN-α2b) IN COMBINATION WITH HIGH-DOSE CELECOXIB AND SYSTEMIC CHEMOTHERAPY

    A PILOT AND FEASIBILITY CLINICAL TRIAL EVALUATING IMMUNO-GENE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA (Ad.hIFN-α... by Sterman, Daniel H, Alley, Evan, Stevenson, James, Friedberg, Joseph, Metzger, Susan, Recio, Adri, Moon, Edmund, Haas, Andrew R, Vachani, Anil, Katz, Sharyn I, Sun, Jing, Heitjan, Daniel F, Hwang, Wei-Ting, Litzky, Leslie, Yearley, Jennifer H, Tan, Kay See, Papasavvas, Emmanouil, Kennedy, Paul, Montaner, Luis J., Cengel, Keith, Simone, Charles B, Culligan, Melissa, Langer, Corey J, Albelda, Steven M

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

    Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy by Cristescu, Razvan, Mogg, Robin, Ayers, Mark, Albright, Andrew, Murphy, Erin, Yearley, Jennifer, Sher, Xinwei, Liu, Xiao Qiao, Lu, Hongchao, Nebozhyn, Michael, Zhang, Chunsheng, Lunceford, Jared K., Joe, Andrew, Cheng, Jonathan, Webber, Andrea L., Ibrahim, Nageatte, Plimack, Elizabeth R., Ott, Patrick A., Seiwert, Tanguy Y., Ribas, Antoni, McClanahan, Terrill K., Tomassini, Joanne E., Loboda, Andrey, Kaufman, David

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

    Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma by Nayak, Lakshmi, Molinaro, Annette M., Peters, Katherine, Clarke, Jennifer L., Jordan, Justin T., de Groot, John, Nghiemphu, Leia, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy R., Cote, David J., Severgnini, Mariano, Yearley, Jennifer H., Zhao, Qing, Blumenschein, Wendy M., Duda, Dan G., Muzikansky, Alona, Jain, Rakesh K., Wen, Patrick Y., Reardon, David A.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    PD-1 blockade induces responses by inhibiting adaptive immune resistance

    PD-1 blockade induces responses by inhibiting adaptive immune resistance by Tumeh, Paul C., Harview, Christina L., Yearley, Jennifer H., Shintaku, I. Peter, Taylor, Emma J. M., Robert, Lidia, Chmielowski, Bartosz, Spasic, Marko, Henry, Gina, Ciobanu, Voicu, West, Alisha N., Carmona, Manuel, Kivork, Christine, Seja, Elizabeth, Cherry, Grace, Gutierrez, Antonio, Grogan, Tristan R., Mateus, Christine, Tomasic, Gorana, Glaspy, John A., Emerson, Ryan O., Robins, Harlan, Pierce, Robert H., Elashoff, David A., Robert, Caroline, Ribas, Antoni

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas

    T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas by Pollack, Seth M., He, Qianchuan, Yearley, Jennifer H., Emerson, Ryan, Vignali, Marissa, Zhang, Yuzheng, Redman, Mary W., Baker, Kelsey K., Cooper, Sara, Donahue, Bailey, Loggers, Elizabeth T., Cranmer, Lee D., Spraker, Matthew B., Seo, Y. David, Pillarisetty, Venu G., Ricciotti, Robert W., Hoch, Benjamin L., McClanahan, Terrill K., Murphy, Erin, Blumenschein, Wendy M., Townson, Steven M., Benzeno, Sharon, Riddell, Stanley R., Jones, Robin L.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: